Evidence map›Paper›PMID 22513312›Full record

ArticleClinical pharmacology and therapeutics2012

The need for translational research on drug-drug interactions.

S Hennessy, D A Flockhart

Abstract readComment
In one paragraph

Article in Clinical pharmacology and therapeutics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Translational drug-interaction corpus.Database : the journal of biological databases and curation · 2022
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Pharmacovigilance using clinical notes.Clinical pharmacology and therapeutics · 2013
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

S HennessyCenter for Clinical Epidemiology, Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. hennessy@upenn.edu
D A Flockhart

Funding

Clinical Importance of Drug-Drug InteractionsR01AG025152 · NIA · UNIVERSITY OF PENNSYLVANIA · PI HENNESSY, SEAN, LI, LANG · 2006 to 2021
$8.1M
Indiana University Comprehensive Training in Clinical PharmacologyT32GM008425 · NIGMS · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI Zeruesenay Desta, Michael Thomas Eadon · 1992 to 2026
$7.7M
Institutional Clinical and Translational Science AwardKL2RR024132 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2006 to 2011
$5.1M
Indiana PREGMEDU10HD063094 · NICHD · INDIANA UNIVERSITY INDIANAPOLIS · PI HAAS, DAVID M. · 2010 to 2014
$4.2M
Indiana University Center for Pediatric PharmacologyU54HD071598 · NICHD · INDIANA UNIVERSITY INDIANAPOLIS · PI RENBARGER, JAMIE L · 2011 to 2015
$3.8M
Drug-Drug Interactions Involving Antidiabetic AgentsR01DK102694 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI HENNESSY, SEAN, LI, LANG · 2014 to 2017
$2.4M
Postdoctoral Research Training in Pediatric Clinical PharmacologyT32HD069047 · NICHD · INDIANA UNIVERSITY INDIANAPOLIS · PI RENBARGER, JAMIE L · 2011 to 2020
$1.9M
Data Infrastructure for Post-Marketing Comparative Effectiveness StudiesRC1AG035751 · NIA · UNIVERSITY OF PENNSYLVANIA · PI HENNESSY, SEAN · 2009 to 2010
$1.0M
NCRR NIH HHS KL2 RR024132NCRR NIH HHS KL2RR024132NIA NIH HHS R01 AG025152NIA NIH HHS R01AG025152NIA NIH HHS RC1 AG035751NIA NIH HHS RC1AG035751NICHD NIH HHS T32 HD069047NICHD NIH HHS T32-HD069047NICHD NIH HHS U10 HD063094NICHD NIH HHS U10HD063094NICHD NIH HHS U54 HD071598NICHD NIH HHS U54HD071598NIDDK NIH HHS R01 DK102694NIGMS NIH HHS T32 GM008425NIGMS NIH HHS T32-GM08425
6 · The paper itself

Abstract

Drug-drug interactions (DDIs) are an important clinical and public health concern. Although DDI screening now occurs during drug development, it is difficult to predict clinical importance based on in vitro experiments. Furthermore, older drugs that were not screened may have interactions that have not yet been identified. In this Commentary, we review the importance of DDIs and argue that a translational research approach is needed to produce clinically actionable information as well as generalizable biological knowledge.

Indexed as

ClopidogrelFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMalePlatelet Aggregation InhibitorsPyridinesTiclopidinecerivastatinClopidogrelHydroxymethylglutaryl-CoA Reductase InhibitorsPlatelet Aggregation InhibitorsPyridinesTiclopidine

Identifiers

PMID22513312
PMCPMC4340251

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.